JOHANNESBURG, 22 March 2021 – The South African government has sold one million doses of the Oxford-AstraZeneca vaccine to other African countries.

South Africa’s health minister, Zweli Mkhize, confirmed the information Monday.

COVID-19 Vaccine Being Fed into Syringe - Photo BusinessLIVE

COVID-19 Vaccine Being Fed into Syringe – Photo BusinessLIVE

The Oxford-Astrazeneca vaccine was sold via the African Union to 14 African countries, the health minister told reporters, without naming the countries.

Only two African countries – the Democratic Republic of Congo and Cameroon – have joined dozens of Western countries in suspending vaccinations using the Oxford-AstraZeneca vaccine over concerns that it caused blood blots.

The World Health Organization has encouraged countries to continue administering the Oxford-AstraZeneca vaccine, contending that even concerns over blood clots do not outweigh the benefits of preventing COVID-19 infection.

South Africa Gets Nine Million J&J Vaccines - Photo Reuters

South Africa Gets Nine Million J&J Vaccines – Photo Reuters

Last month, South Africa cancelled plans it had to roll out the vaccine, citing a study which found that the Oxford-AstraZeneca vaccine had a “minimal” effect against the country’s new variant of COVID-19.

Health workers across South Africa are currently being inoculated using the single-dose Johnson & Johnson vaccine.

South Africa has already received nine million doses of the Johnson & Johnson vaccine.

As of Monday, South Africa had recorded 1.54 million cases of COVID-19 with 52,111 deaths so far – the most by any African country and nearly half the deaths continent-wide.

Africa had confirmed 4.1 million COVID-19 cases with 109,893 fatalities, according to the most updated data published Monday by Africa Centers for Disease Control.

Subscribe To Our Newsletter

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our team. This month, a reverting one on one interview with the Chairman on African Affairs at IMF

You have Successfully Subscribed!